Thermo Fisher enters into agreement Fujirebio

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

Singapore: Thermo Fisher Scientific signed a long-term license agreement with Fujirebio to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory ins...Read more

Bayer colorectal cancer drug gets Japanese nod

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's Stivarga (regorafenib) tablets for the treatment of patients with me...Read more

Astellas, Ambit terminate cancer drug deal

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint development and commercialization of FMS-like tyrosine kinase-3 (FLT3)...Read more

Edison Pharma, DSP enter $4 bn metablosim drug deal

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan's Dainippon Sumitomo Pharma (DSP) for the development of drugs target...Read more

Gilead files NDA for Hep C drug in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-daily nucleotid...Read more

AnGes, Mitsubishi Tanabe sign MoU to market Collategene

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with HGF gene) as a treatment for peri...Read more

What the future holds for the APAC CRO market?

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Japan scientists pioneer new stem cell technology

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

Astellas gets FDA nod for kidney transplant drug

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kid...Read more

Global collaborations is the way forward for drug discovery

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more

Pfizer, Mylan enter generics deal in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2012

Singapore: Pfizer and Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration in order to develop, manufacture, distribute and market generic dr...Read more

Takara Bio enters deal with Invivoscribe

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

Singapore: Japanese firm Takara Bio has entered into an agreement with Invivoscribe Technologies to grant the latter licenses to facilitate and conduct patent-covered tests for the presence...Read more

NuVasive spine surgery implant approved in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

Singapore: NuVasive, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, has received Japan's approval of the CoRoent Large ...Read more

Mitsubishi to acquire Medicago at $1.16 per share

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and virus-like particles (VL...Read more

Kinetic launches portable negative pressure therapy

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Apr, 2013

Singapore: US-based Kinetic Concepts (KCI) has launched ActiVAC Therapy System for in-patient use in Japan, which is a lightweight, portable negative pressure therapy system that makes usin...Read more

Terumo and Biosensors to sell Nabori DES system

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Terumo and Biosensors International announced an extension of their existing licensing agreements, under which Terumo can continue to incorporate BioMatrix technology in the...Read more

Otsuka, Lundbeck files NDA for schizophrenia drug

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

HealthPatch MD receives Japanese nod

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2015

Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in the Japanese markets. The device has received, Medical Device Ninsho ce...Read more